NRAS mutation status is an independent prognostic factor in metastatic melanoma.
Jakob JA, Bassett RL Jr, Ng CS, Curry JL, Joseph RW, Alvarado GC, Rohlfs ML, Richard J, Gershenwald JE, Kim KB, Lazar AJ, Hwu P, Davies MA.
Jakob JA, et al.
Cancer. 2012 Aug 15;118(16):4014-23. doi: 10.1002/cncr.26724. Epub 2011 Dec 16.
Cancer. 2012.
PMID: 22180178
Free PMC article.